< Back to catalogue
Mavacamten
August 4, 2026Sacubitril + Valsartan + Dapagliflozin
August 5, 2026PHARMAZAC
Resmetirom
Resmetirom | THR-β Agonist | Business Development
| F.C. TABS 60 MG/TAB |
| F.C. TABS 80 MG/TAB |
| F.C. TABS 100 MG/TAB |
| F.C. TABS 60 MG/TAB |
| F.C. TABS 80 MG/TAB |
| F.C. TABS 100 MG/TAB |
| ACTIVE SUBSTANCE | |
|---|---|
| MARKETING AUTHORISATION HOLDER | |
| PHARMACOLOGICAL CLASS | |
| PRESCRIPTION REQUIREMENT | |
| STATUS | In Process |
| THERAPEUTIC AREA |
